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THE MODERATING ROLE OF EMOTION REGULATION IN THE RELATIONSHIP 
 BETWEEN STRESS AND INFLAMMATORY BOWEL DISEASE SEVERITY 
AMONG DIAGNOSED INDIVIDUALS 
SARAH M. GHOSE 
ABSTRACT 
 This study examined whether both perceived and objectively rated chronic stress 
are contributing external factors to altered Inflammatory Bowel Disease (IBD) disease 
severity among diagnosed individuals. This study further examined whether emotion 
regulation (ER) acts as an ameliorative factor within this relationship. Of additional 
interest to this investigation was whether objectively rated stress (acquired via the UCLA 
Life Stress Interview) provided a unique contribution to this relationship. Recent 
investigations suggest that higher levels of perceived stress may result in increased IBD 
severity. Further, ER deficits may be associated with increased IBD disease activity in 
response to both chronic and perceived stress. Participants (N=30) completed measures of 
perceived and chronic stress, ER, and disease severity. Multiple moderation models were 
examined to determine the moderating role of ER (both adaptive and maladaptive) within 
relationships between both perceived and chronic stress and disease severity (measured 
by the Harvey Bradshaw Index). No ER moderation effect was observed in the 
relationship(s) between objective and perceived stress ratings and IBD disease severity. 
However, results do suggest that adaptive and maladaptive ER significantly influence 
disease severity (decreased and increased respectively) independent of both objective and 
perceived stress ratings. These findings suggest the utility of ER-informed 
psychoeducation and interventions in the treatment and maintenance of IBD. 
 Keywords: inflammatory bowel disease, stress, emotion regulation, disease severity  
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CHAPTER I 
INTRODUCTION 
Inflammatory Bowel Disease (IBD) is a term used to refer to both Crohn’s 
Disease (CD) and Ulcerative Colitis (UC). IBD is highly prevalent and affects 
approximately 7,000 to 47,000 individuals living in the United States and Canada each 
year (Crohn’s and Colitis Foundation of America, 2015; Loftus, 2004). IBD symptom 
expression is characterized by periods of “flares” and remission(s); nearly 25-50% of 
individuals diagnosed with IBD “relapse”, or experience active expression of disease, 
each year (Crohn’s and Colitis Foundation of America, 2015; Riley, Mani, Goodman, & 
Lucas, 1990; Sewitch, et al., 2001).  Individuals are typically diagnosed with IBD when 
they are 15 to 35 years old (Crohn’s and Colitis Foundation of America, 2015; Sewitch, 
et al., 2001). Further, the risk of mortality as a result of complications brought on by UC 
and/or CD approximates 50% in the first one to two years following initial diagnosis 
(Carter, Lobo & Travis, 2004; Murray, 1984).  
Existing medical interventions for IBD can cost an individual with IBD anywhere 
from $5,066 to $18,963 annually (Crohn’s and Colitis Foundation of America, 2015). 
IBD’s impact can be felt not only individually, but nationally as well. In fact, the IBD 
financial burden in the U.S. is markedly high, with the total annual economic cost for 
 
                                   
 
 2 
treatment of IBD estimated at $14.6 billion to $31.6 billion (Crohn’s and Colitis 
Foundation of America, 2015; Gibson, et al., 2008). For these reasons, it is important to 
identify factors that contribute to disease exacerbation, disrupting periods of decreased, 
or even remitted, disease activity.  
 Among the myriad of identified risk factors for IBD onset and exacerbation, 
stress, specifically chronic subjective (perceived) stress, has received much attention 
(Bhatia & Tandon, 2005; Danese, Sans, & Fiocchi, 2004; Felton, Revenson & 
Hinrichsen, 1984; Soderholm, et al., 2002). While objective stress has been largely absent 
in the literature, there is evidence suggesting it may be worth investigating. Objective 
stress approximation measures may in fact provide for a more impartial examination of 
the stress-disease severity relationship (Hammen, Kim, Eberhart & Brennan, 2009; 
Naliboff, et al., 2008). Thus, the investigation of both types of stress is indicated in order 
to gain a more comprehensive understanding of the relationship between stress and IBD.  
Investigation into client-directed stress mitigation tools may provide individuals 
with the ability to modify the potential impact of everyday external factors, such as stress, 
on IBD severity. Emotion regulation (ER) strategies are one such “tool” that may play a 
substantial role in mitigating the effects of stress on disease course (Mattlin, Wethington 
& Kessler, 1990; Wang & Saudino, 2011). Maladaptive attempts to deal with disease 
related stressors are known to contribute to poor IBD outcomes, while the use of adaptive 
emotion regulation strategies could lessen such deleterious effects of stress on IBD 
(Danese, Sans & Fiocchi 2004; Danesh, Cholamrezaei, Torkzadeh, Mirbagher, Sloku & 
Emami, 2015; Hall & Rubin, 2005; Iglesias-Rey, et al., 2013; Wolfe & Sirois, 2008). The 
present study aims to examine the relationship between perceived and objective stress, 
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IBD severity, and ER with the goal to determine whether ER acts as a moderator in this 
relationship. 
Importantly, the proposed project is part of a larger investigation comprised of a 
number of emotion and trait-related measures, collected in part via Ecological 
Momentary Assessment (EMA). The current study will solely utilize self and interview-
reports of individual stress (chronic stress specifically) and self-report emotion regulation 
utilization and disease severity data collected as a part of the larger endeavor. 
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CHAPTER II 
BACKGROUND 
2.1 Inflammatory Bowel Disease: Overview 
“IBD” refers to autoimmune diseases that affect the gastrointestinal (GI) tract: UC 
and CD. While individuals with either UC or CD share many similar and/or identical 
symptoms, the main distinction between these two disease subtypes lies in the location of 
disease within the body. UC is limited to the colon while CD has the potential to affect 
any part of the GI tract (Carter, Lobo & Travis, 2004; Crohn’s and Colitis Foundation of 
America, 2015; Schwarz & Blanchard, 1990). Symptoms of active disease include: 
abdominal pain, fatigue, blood and mucus in stool, joint pain, ulcers in small and large 
intestine(s), fecal frequency, weight loss, anemia, diarrhea, nausea, “brain fog” 
(confusion/disorientation and/or inability to think clearly), strictures (most commonly 
scarring causing GI blockage), fistulas (open connections between two strictures and/or a 
stricture with nearby organ tissue), abscesses, and eye inflammation (uveitis) (Carter, 
Lobo, & Travis, 2004; Greene, Blachard & Wan, 1994; Murray, 1984; Schwarz & 
Blachard, 1990; Wolfe & Sirois, 2008). The course of IBD is unpredictable, pervasive, 
and at times debilitating. 
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The course of IBD is marked by recurrent periods of remissions and flares. 
“Flare" is a term used to refer to an active exhibition of symptoms. Further, the term 
“remission” is used here to indicate an absence of active disease, achieved organically, 
natural submission of disease, or clinically, achieved via pharmacological agents (Bitton, 
et al., 2008; Bitton, et al., 2003; Riley, Goodman & Lucas, 1990).  
Medication, diet change, exercise, and surgery are currently the most readily 
accepted and implemented interventions for the treatment of IBD. These treatments are 
employed with the aim to reduce inflammation, not to eliminate the disease (Crane & 
Martin, 2004; Crohn’s and Colitis Foundation of America, 2015; Sajadinejad, Asgari, 
Molavi, Kalantari & Adibi, 2012; Wolfe & Sirois, 2008). While IBD can be managed by 
a multitude of interventions, it is a lifelong disease that ultimately cannot be cured, even 
by surgical intervention (considered as a last option for those with severe disease and/or 
with acute complications) (Wolfe & Sirois, 2008).  
As autoimmune diseases are often co-morbid, there is a high possibility that an 
individual suffering from IBD may have another chronic/auto-immune condition, or even 
cancer (colorectal cancer in the case of IBD) (Cooper, Bynum & Somers, 2009; Somers, 
Thomas & Hall, 2009; Greene, Blanchard & Wan, 1994; van der Have, et al., 2015; 
Herszenyi, Barabas, Miheller & Tulassay, 2015). IBD also has the potential to contribute 
to the individual’s psychological distress and functional impairment (Dunne & Cook, 
2005). The effects of IBD on an individual’s daily functioning can potentially reduce his 
quality of life either temporarily, during active disease expression, and/or permanently, in 
the case of severe IBD. Identified factors affecting IBD-specific Health Related Quality 
of Life (HRQOL) (disease relevant impact on daily functioning and outlook) include 
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disease longevity, disease severity, and internalizing factors, such as depression and 
anxiety, incurred and/or exacerbated as the result of the chronic illness (Graff, Walker, 
Clara, Lix, Miller, Rogala, Rawsthorne & Bernstein, 2009; Irvine, 2004; Sajadinejad, 
Asgari, Molavi, Kalantari, & Abidi, 2012). 
IBD’s chronic course not only impacts an individual physically, but can also 
substantially impact one socially, occupationally, and psychologically. Examples of 
IBD’s potentially adverse impact on the social domain include interruption of plans due 
to frequent bathroom trips, embarrassment about the disease, social isolation, cancelling 
plans, feeling burdensome, romantic and friendship relationship strain, unease about 
dating, and fear of intimacy (Casati, Toner, de Rooy, Drossman & Maunder, 2000; 
Sajadinejad, Asgari, Molavi, Kalantari, & Abidi, 2012).  
In the workplace, unfavorable consequences may arise as the result of leaving 
work early, not going to work, performing poorly due to IBD symptoms, and/or having to 
schedule around sick days, doctors’ visits, hospitalizations, and/or surgeries. Further, it 
may be the case that those who used to work simply cannot continue as a result of their 
disease (Wolfe & Sirois, 2008). In fact approximately 34% of diagnosed individuals do 
not work due to their IBD diagnoses and 18.3% are on full disability, despite lifestyle, 
surgical, and pharmaceutical interventions (Graff, et al., 2006; van der Valk, et al., 2014). 
IBD has the potential to impact the diagnosed individual’s psychological health as 
well as their relationships and career. The unpredictable course of the disease may 
culminate into concerns about appearance (due to surgeries, medication, or weight loss), 
worries about the future, and fears of pain, disability, and worsening of disease (Casati, 
Toner, de Rooy, Drossman & Maunder, 2000; Sajadinejad, Asgari, Molavi, Kalantari, & 
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Abidi, 2012). Actually, compared to the general, healthy population, those diagnosed 
with IBD have expressed significantly higher levels of anxiety and depression as a 
function of their disease severity (Danesh, Cholamrezaei, Torkzadeh, Mirbagher, Sloku 
& Emami, 2015; Kurina, Goldacre, Yeates, & Gill, 2001; Voth & Sirois, 2009). The 
tangible impact of IBD is multifaceted, not solely limited to one’s experience of the 
physical body state; IBD’s widespread effect points toward the significance of identifying 
those factors that contribute to IBD’s presence and expression within the body. 
A variety of factors suspected to contribute to the onset of IBD include “ex-
smoker” status, diet, mycobacterial infection, genetic predisposition, perinatal infections, 
and environmental triggers (Carter, Lobo & Travis, 2004; Crohn’s and Colitis Foundation 
of America, 2015; Danese, Sans, & Fiocchi, 2004; Loftus, 2004). Despite the existence of 
numerous theories, there exists no single indisputable factor, or set of factors, responsible 
for IBD onset; the etiology, or cause, of IBD is ultimately unknown. 
Just as there is no consensus in the field on what causes IBD, there is just as little 
certainty surrounding what triggers flare-ups of the disease. Despite this uncertainty, one 
risk factor for IBD exacerbation that has received much attention in the literature is stress 
(Danese, Sans, & Fiocchi, 2004; Levenstein, et al., 2000). On average, individuals with 
IBD do experience episodes of disease that lessen, if not remit, in severity. In order to aid 
those with IBD in achieving lengthened periods of decreased disease expression, it will 
be important to understand the relationship between prominent external risk factors, such 
as stress, and IBD severity.  
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2.2 The Role of Stress in IBD  
Stress has historically been suspected to be, and more recently has been accepted 
as, a risk factor for exaggerated IBD severity (Mattlin, Wethington & Kessler, 1990; 
Naliboff, Mayer, Fass, Fitzgerald, Chang, Bolus & Mayer, 2004; Sajadinejad, Asgari, 
Molavi, Kalantari, & Abidi, 2012). In the past, the relationship between stress and IBD 
was considered nothing more than “anecdotal” or “psychosomatic” (Murray, 1984; 
Sajadinejad, Asgari, Molavi, Kalantari, & Abidi, 2012).  Presently, stress has attained 
more credibility as a factor contributing to IBD disease activity.  
Stress can be divided into two broad categories: “perceived” and “objective”. 
Perceived stress refers to the individual’s subjective experience of stressful events while 
objective stress pertains to the unbiased, “average interpretation”, perception of 
adverse/stressful events. Surprisingly, objective stress remains largely, if not completely, 
absent in the current IBD literature base. Historically, measures of perceived stress have 
been utilized in approximation of the impact of stress on IBD expression. However, the 
potential for unique and novel insight into the impact of stress on IBD, coupled with the 
topic’s absence in the literature, suggests an additional need to investigate the unique 
contribution that objective stress may provide to IBD research (Iglesias-Rey, Barreiro-de 
Acosta, Caamano-Isorna, Vazquez-Rodriguez, Gonzalez, Lindkvist & Dominguez-
Munoz, 2013; Levenstein, Prantera, Varvo, Scribano, Berto, Andreoli & Luzi, 1994; 
Mawdsley & Rampton, 2005; Levenstein, Prantera & Varvo, 2000). 
Traditionally, objective measures of stress have included such interventions as the 
monitoring and measurement of inflammatory marker or cortisol levels and/or 
psychophysiological activity, such as respiratory sinus arrhythmia, in response to 
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predetermined target stimuli (Gentzler, Santucci, Kovacs & Fox, 2009; Wolf, Nicholls & 
Chen, 2008). However, objective ratings of stress, derived from such interview tools as 
the UCLA Stress Interview, have been established as a well-validated alternative in the 
approximation of objective stress (See “Methods” section for further information on how 
objective stress ratings are calculated) (Hammen, Kim, Eberhart & Brennan, 2009; Wolf, 
Nicholls & Chen, 2008; Kim, Miklowitz, Biuckians & Mullen, 2007; Naliboff, Mayer, 
Fass, Fitzgerald, Chang, Bolus & Mayer, 2004). These objective ratings can allow for 
further insight into the objective experience underlying self-reported stress experiences. 
Just as stress can be categorized as either perceived or objective, it can further be 
classified as “episodic” (discrete events spanning 1 to 3 months) or “chronic” (ongoing 
events spanning at least 6 months) (Lepore, Miles & Levy, 1997). Although both episodic 
and chronic stress have been shown to increase IBD severity in both human and animal 
subjects (Collins, McHugh, Jacobson, Khan, Riddell, Murase, & Weingarten, 1996; 
Soderholm, Yan, Ceponis, Vohra, Riddell, Sherman & Perdue, 2002), attention in health-
related research is often placed on chronic stress as its impact is ongoing and cumulative. 
The cumulative nature of chronic stress allows for physiological responses (such as 
increased breathing and heart rate) that are meant to be adaptive to lead to maladaptive 
health consequences in the long run (DeSteno, Kubzansky, & Gross, 2013). As such, 
chronic stress is more likely than episodic stress to play a substantial role in affecting 
disease severity and exacerbation. 
Chronic stress has the capability to affect both immune system and inflammatory 
functions, leading specifically to heightened immunosuppression and inflammation 
(Glaser & Kiecolt-Glaser, 2005; Mawdsley & Rampton, 2005; Danese, Sans, & Fiocchi, 
 
                                   
 
 10 
2004) in all individuals regardless of level of health. In fact, Cohen, Tyrrell, and Smith 
(1993) discovered that even otherwise healthy individuals exposed to stress experienced 
an increased linear rate of contracting the common cold. Indeed, chronic stress been 
evidenced to have a profound effect on disease course in IBD patients (Danese, Sans, & 
Fiocchi, 2004; Levenstein, et al., 2000; Mattlin, Wethington, & Kessler, 1990). 
Heightened stress has not only been shown to exacerbate IBD symptoms, such as 
abdominal pain and worsened immune function, but also to contribute to the increased 
risk for a remissive patient to relapse into active disease (Bitton, et al., 2008; Glaser & 
Kiecolt-Glasier, 2005; Lepore, Miles & Levy, 1997; Sajadinejad, Asgari, Molavi, 
Kalantari, & Abidi, 2012; Mawdsley & Rampton, 2005).  
Stress is, for better or worse, a normal part of life. Individuals with IBD are 
regularly faced with several chronic stressors relative to both daily life experiences and 
disease course. As stress is a readily identifiable and salient factor with evidenced impact 
upon IBD disease severity, it follows that processes that can modify the degree to which 
varying levels of stress alter IBD expression be identified. One such modifiable process 
that is of particular interest to the proposed project is emotion regulation (ER). 
2.3 Emotion Regulation: A Protective Factor Against Stress 
When considering the role that ER may play in the relationship between IBD and 
stress, it is important to first make the distinction between “ER” and “coping”. “Coping” 
and “ER”, appearing at first to be unique terms, actually share “permeable boundaries” 
(Gross, 1998); both terms appear in the literature broadly as terms demarcating strategies 
used to ameliorate distress. “ER”, due to its large presence in related behavioral medicine 
literature, is to be utilized within the current proposal to maintain consistency. 
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“ER”, known to attenuate stress (Bitton, et al., 2008; DeSteno, Kubzansky, & 
Gross, 2013; Mattlin, Wethington & Kessler, 1990; Wang & Saudino, 2011), refers to the 
adaptive and maladaptive modifiable behavioral and/or cognitive process by which an 
individual can impact not only the emotions they experience, but also how they 
experience them (Folkman, Lazarus, Dunkel-Schetter, DeLongis & Gruen, 1986; Gross, 
1998, 2002; Wang & Saudino, 2011). Individuals suffering from chronic, lifelong 
conditions/diseases, such as IBD, attempt to employ ER strategies, adaptive and/or 
maladaptive, to address associated challenges (Garnefski, Koopman, Kraaij & ten Cate, 
2009; de Ridder, Geenen, Kuijer & van Middendorp, 2008; Kaptein, Hazes, Willems, 
Bergman & Rooijmans, 1997; Kiebles, Doerfler & Keefer, 2010). The ER strategies that 
individuals utilize in response to stress ultimately play an important role in determining 
their “medical outcomes” (Scharloo, Kaptein, Weinman, Hazes, Willems, Bergma & 
Rooijmans, 1997). 
Deleterious effects on health due to stress do not happen in one instance and/or 
after a single utilization of a maladaptive ER strategy. It is the repeated use of 
maladaptive ER strategies in response to chronic stressful experiences that allows for 
unfavorable health outcomes (Danese, Sans, & Fiocchi, 2004; Glaser & Kiecolt-Glaser, 
2005; Gross, 2002; Lepore, Miles & Levy, 1997). In fact, referencing the prior mentioned 
study conducted by Cohen, Tyrrell, and Smith (1993), those with increased negative 
affect and stress levels experienced additional increased rates of contracting the common 
cold. Bernstein et al (2010) found similar results indicating that diagnosed individuals 
experiencing high perceived stress rates, coupled with negative affect, were significantly 
more likely to experience a flare-up of disease activity. Chronic stress, coupled with 
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exacerbation of this stress through the consistent use of maladaptive ER strategies to deal 
with, has the potential to incite worsened IBD outcomes. 
Typically, it is the case that maladaptive ER strategies are helpful in the short 
term, yet harmful to the individual in the long term (Felton, Revenson & Hinrichsen, 
1984; Gross, 1998, 2002; Kovacs, Rottenberg, & George, 2009). It has been historically 
evidenced that engaging in maladaptive emotion-focused strategies, such as “distancing” 
and “escape avoidance”, to deal with distress leads to worsened outcomes compared to 
utilization of more adaptive problem-focused strategies (Folkman, Lazarus, Dunkel-
Schetter, DeLongis, & Gruen, 1986). Such ER deficits are known to worsen health and 
functioning among those with IBD (Danesh, Gholamrezaei, Torkzadeh, Mirbagher, 
Soluki & Emami, 2015; Iglesias-Rey, et al., 2013). Danesh et. al. (2013), in a study on 
coping style utilization in the IBD population and coping style impact on disease activity, 
discovered, at the trend level, that the use of such maladaptive ER strategies as fatalism 
resulted in increased disease activity. In fact, it is well established that individuals 
diagnosed with IBD tend to engage significantly more in maladaptive coping than 
controls (Danesh, Gholamrezaei, Torkzadeh, Mirbagher, Soluki & Emami, 2015; Greene, 
Blanchard, & Wan, 1994; Iglesias-Rey, et al., 2013). Given that there are measurable, 
harmful consequences of using maladaptive ER strategies, identifying the utility of 
adaptive ER strategies for diagnosed individuals is readily indicated. 
Adaptive ER strategies are those that successfully achieve the goal of 
ameliorating distress and are actually beneficial in the long term (Felton, Revenson & 
Hinrichsen, 1984; Gross, 1998, 2002). Trend level significance has been reported by 
Greene, Blanchard, and Wan (1994) and Danesh et al. (2015) regarding the impact that 
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adaptive ER has on maintaining or decreasing disease severity. (It is of note that these 
studies utilized mediation models of ER, whereas the current project hopes to utilize a 
moderation model discussed later). Further, not all findings regarding ER and IBD 
severity have resulted in null or trend level findings. In fact, a recent study on ER and 
inflammation, conducted by Appleton, Gilman, Kubzansky, Buka, and Loucks (2013), 
determined that maladaptive emotion regulation heightened inflammation levels (defined 
as levels of plasma C-reactive protein or CRP), while the use of adaptive emotion 
regulation resulted in significantly lower inflammation levels. The modifiable process of 
ER strategy utilization can actually influence disease severity in a measurable way. 
The link between perceived stress/objective ratings of perceived stress, ER, and 
IBD disease severity ultimately remains unknown. The current investigation strives to 
highlight, and potentially reveal,  this hypothesized relationship structure in order to 
inform both the research community and interventions to give diagnosed individuals the 
best chance at maintaining disease remission and/or stability even when faced with daily 
life stressors. 
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CHAPTER III 
THE CURRENT STUDY 
Existing studies have indeed attended to ER, perceived stress impact, ER/coping, 
and IBD disease severity outcomes. However, a study has not yet been conducted that 
assesses these areas concurrently.  
Prior studies have focused primarily on the mediating role of ER/coping in 
illness-guided/related relationships (Danesh, Cholamrezaei, Torkzadeh, Mirbagher, Sloku 
& Emami, 2015; Scharloo, Kaptein, Weinman, Hazes, Willems, Bergman & Rooijmans, 
1997; Voth & Sirois, 2009). These prior investigations operated on the assumption that 
external factors, such as chronic stress, directly influenced the ER strategies employed by 
an individual, thus further influencing the disease-related outcome of interest as a result. 
However, the current investigation seeks to decipher whether ER plays a moderating role 
in the present two-variable (stress and IBD severity) relationship model (See Appendix 
B, Figure 1). Investigating ER as a potential moderator in this proposed relationship 
model is a deliberate choice made with the goal to extricate any influence of variation in 
stress level solely on the hypothesized relationship. This allows for the relationship to be 
analyzed in such a way that there is something inherent to the stress experienced by those 
with IBD that is directly influenced by ER itself, and not any other artifact, which has a 
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further impact on incurred disease outcomes. Artifactual influences, perhaps variation in 
stress level in this case, could not so easily be ruled out via utilization of a mediation 
model. A moderation model is thus appropriate for the aims of the current investigation, 
allowing for the provision of focused analysis on the relationship between stress and IBD 
disease exacerbation, wherein ER may be found to act as a direct intervening factor. The 
current investigation aims to answer the questions, “Under what conditions are 
individuals diagnosed with IBD most susceptible to the impact of stress on disease 
severity?” and “Under what conditions are individuals diagnosed with IBD least 
susceptible to the impact of stress on disease severity?” Positioning ER as a potential 
moderator in the current project, directly impacting the relationship rather than mediating 
it, will allow for a reasonable and appropriate attempt at answering both parts of this 
question (Bitton, et al., 2008; MacKinnon & Luecken, 2008). 
 The current study aims to determine whether the objectively rated stress has a 
unique contribution in the relationship between chronic stress and disease severity. It is 
predicted that objective ratings of stress will indeed account for a unique amount of 
variance, above and beyond perceived stress, between stress and disease severity 
(Hypothesis 1). A further aim of this investigation is to explore the potential moderating 
role that ER serves in the relationship between stress experience and IBD severity, with 
the expectation that increased adaptive ER utilization will buffer the effects of stress, 
both perceived and objectively rated, on IBD severity and increased maladaptive ER 
utilization will augment the effects of stress on IBD severity (Hypothesis 2). 
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CHAPTER IV 
METHODS 
4.1 Participants 
The sample consisted of 30 individuals diagnosed with either UC or CD (86.7% 
female, 96.7% Caucasian, Mage= 43, SD= 13.14 years) (Table I). Individuals were eligible for 
participation in the study if they were at least 18 years of age with one of the 
aforementioned diagnoses. Participants were recruited nationally via ResearchMatch, an 
online database that matches individuals with study opportunities according to specified 
qualifying characteristics (Harris, Scott, Lebo, Hassan, Lighter & Pulley, 2012). 
Participants who completed the study were compensated $30.00 for their efforts.  
4.2 Procedure 
 All interested and eligible participants were contacted via email and/or telephone 
call. Initial email contact provided eligible participants with further study information, 
initial survey and consent form links. Upon completion of consent and preliminary 
survey items, interested parties were contacted in order to schedule a date and time 
convenient for them to complete an approximately one-hour long stress interview (UCLA 
Life Stress Interview) over the phone. 
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4.3 Instruments 
 Demographic information. The demographic questionnaire utilized for this 
study included nine items pertaining to age, sex, education, ethnicity, occupation, and 
IBD diagnostic information.  
 Emotion regulation strategies. The Feelings and Me Scale (FAM) is a 54-item 
scale assessing utilization of adaptive and maladaptive coping strategies across social, 
cognitive, and behavioral domains in response to emotional experiences. Responses are 
made on a 3-point Likert scale to such items as “When I feel sad or down I: throw, kick, 
or hit objects.” The FAM scale is reasonably valid and reliable, with α=.80 to .91 
(Kovacs, Rottenberg & George, 2009). Internal consistency statistics for both 
maladaptive and adaptive sub-scales were α=.84 within the current study.  
 Perceived stress. Cohen’s Perceived Stress Scale (PSS) is a 10-item 
questionnaire assessing individual perceptions of stress, specifically how “unpredictable, 
uncontrollable, and overloaded [participants] find their lives” (Cohen, 1988). Responses 
are made on a 5-point Likert scale to such items as “In the last month, how often have 
you felt that you were unable to control the important things in your life?” The PSS is 
considered to be a reliable and valid measure (α=.78) (Cohen & Williamson, 1988). 
Internal consistency of this measure in the current investigation was α=.90. 
Disease severity. The Harvey Bradshaw Index (HBI) is a 5-item survey assessing 
IBD disease severity/activity. Item 1 is responded to on a 5-point Likert scale, items 2 
and 4 on a 4-point Likert scale, item 3 is open response, and item 5 allows an individual 
to endorse as many options as apply. The survey includes such items as “General well-
being (yesterday): very well, slightly below par, poor, very poor, terrible.” The HBI was 
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originally designed for use with patients with CD solely, in order to replace a more 
“complex measure”, the CDAI (Clinical Disease Activity Index); however, research has 
established this scale to have just as much utility for patients with UC (Sewitch, et al., 
2001). The CDAI has an internal consistency of α= .5 to .7, and the HBI was shown to 
correlate at r=.93 with this measure (Salaffi, Cimmino, Leardini, Gasparini, & Grassi, 
2009; Harvey & Bradshaw, 1980). Internal consistency of this measure in the current 
investigation was α=.62.  
Chronic stressful life events. The UCLA Life Stress Interview is an 
approximately one-hour long interview that gathers information pertaining to individual 
experiences of chronic and episodic stress. (Chronic and episodic stress were defined as 
time periods of 6 months and 3 months prior to the date of interview for this investigation 
specifically). Participants are prompted with questions related to the following domains: 
Intimate Relationships, Close Friends, Social Life, Family Relationships, Relationships 
with Children, Occupation, Finances, and Health. Following completion, each domain is 
assigned a score on a scale from 1, being “no difficulty” to 5, “severe/persistent” 
difficulty” (Hammen, Kim, Eberhart & Brennan, 2009; Nicholls & Chen, 2008) by a 
trained team of raters.  
A team of four objective raters, per UCLA Life Stress Interview scoring protocol, 
was trained to evaluate and score brief interview transcriptions for each participant. 
Raters met regularly with a supervisor trained in this scoring modality. Training on 
scoring protocol included discussion of manual procedures, scoring, and practice cases. 
Raters trained in this manner in order to gain a practical understanding of both the 
process and criterion that would qualify assignment of a particular rating (1 through 5) 
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for each chronic stress domain. Within the current investigation, an overall chronic stress 
value for each participant was determined by totaling the team’s assigned ratings across 
domains (Hammen, Kim, Eberhart, & Brennan, 2009).  
This measure has been deemed both reliable and valid, with internal consistency 
of α=.65 for the scale in total, and α= .86 to .94 pertaining to chronic stress alone 
(LeBovidge, Lavigne & Miller, 2005; Hammen & Rudolph, 1999). Internal consistency 
for the chronic stress measure in the current investigation surfaced as α=.76. 
4.4 General Methods of Analysis 
All statistical analyses were completed utilizing IBM SPSS Version 24 software. 
Preliminary analyses revealed that no data were missing from target measures. 
Moderation analyses were conducted utilizing the PROCESS Macro Version 3 Add-On 
for SPSS Version 24 (analyses utilized PROCESS Model 1 specifically) (Hayes, 2018). 
PROCESS moderation analyses were run utilizing confidence intervals bias-corrected at 
95% as well as bootstrapping estimates calculated with 50,000 samples.  
H1: Hierarchical regression models were analyzed to determine the effect that 
objectively rated levels of stress have on disease severity in addition to the effects of 
perceived stress. Covariates were included in the model in order to eliminate as much 
variance due to individual differences as possible. The choice to place covariates into 
regression analyses was made deliberately with the aim to attain improved accuracy in 
the study of target predictor-outcome relationships. The “R-squared change” statistic was 
utilized to determine whether UCLA objective stress ratings indeed accounted for a 
significant amount of variability in disease severity outcomes compared to perceived 
stress alone.  
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H2: The PROCESS Macro was utilized to assess the moderating effects of 
adaptive and maladaptive ER on the relationship between perceived and chronic stress 
and disease severity in line with the proposed model (Appendix B, Figure 1). Prior to 
running moderation analyses, data were assessed for extreme values and violations of 
necessary assumptions (linear relationships between independent variables and outcome 
variable, normally distributed residuals, homoscedasticity, and lack of multicollinearity 
between independent variables) (Hair, Black, Babin & Anderson, 2009), revealing no 
significant deviations. Parallel hierarchical regression analyses were run in order to 
garner contextual coefficient and standard error statistics for relationships between target 
variables attained via PROCESS software (Tables IV-VII). 
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CHAPTER V 
RESULTS 
5.1 Descriptive Analyses 
Descriptive statistics (means and standard deviations) and bivariate correlations 
are presented in Table II. As expected, higher levels of perceived stress correlated 
significantly with higher levels of objectively rated stress. Further, increased use of 
maladaptive emotion regulation strategies was significantly related to increased levels of 
perceived stress, chronic stress, and disease severity. Notably, frequent use of adaptive 
emotion regulation strategies was negatively related to disease severity. No other 
variables were correlated at significant or trend levels (see Table II). 
5.2 Hypothesis 1  
“Objective ratings of stress will account for a unique amount of variance, above 
and beyond perceived stress, between stress and disease severity.” Hierarchical 
regression models were fit to examine this hypothesis. The first model block included 
demographic characteristics, age and sex, the second perceived stress, and the third 
objective stress ratings. Contrary to expectation, neither perceived stress nor objective 
stress ratings emerged as significant predictors of disease severity (see Table III).   
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5.3 Hypothesis 2 
“Increased adaptive ER utilization will buffer the effects of stress, both perceived 
and objectively rated, on IBD severity and increased maladaptive ER utilization will 
augment the effects of stress on IBD severity.”  
This hypothesis was tested via a series of hierarchical regression analyses that 
included demographic characteristics in the first step, the stress measure in the second 
step, emotion regulation measure in the third step, and the interaction of between the 
stress measure and emotion regulation index in the final step. Each model tested one 
measure of stress and emotion regulation, which resulted in four hierarchical regression 
models. Across all models, neither demographic characteristics, nor the two stress indices 
emerged as significant predictors of disease severity. In contrast, adaptive and 
maladaptive ER repertoires significantly predicted lowered and elevated levels of disease 
severity respectively (see Tables IV-VII). Contrary to expectation, neither adaptive nor 
maladaptive ER indices moderated the effects of the two stress measures. 
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CHAPTER VI 
DISCUSSION 
 The current research study investigated the role of ER in the relationship between 
chronic, objectively rated, stress and perceived stress, and Inflammatory Bowel Disease 
(IBD) disease severity. Inflammatory Bowel Disease is one of many autoimmune 
diseases in which maladaptive attempts to deal with disease-related stress can result in a 
protracted disease course (Kiecolt-Glaser, McGuire & Robles, 2002; Pellissier, Dantzer, 
Canini, Mathieu, & Bonaz, 2010). A body of work suggests that objective measures of 
stress diverge in their effects on biological processes from the effects of perceived stress 
(e.g., chromosome methylation) (Vidal, Benjamin Neelon, Liu, Tuli, Fuemmeler, Hoyo, 
Murtha, Huang, Schildkraut, Overcash, Kurtzberg, Jirtle, Iversen & Murphy, 2014).  
However, the relative contribution of such stressors to IBD severity is not known, nor is 
it clear whether ER responses differentially modify their effects. As ER has recently 
surfaced as an important psychosocial factor that affects “immune-related health 
outcomes”, not only for IBD, but also for such diseases as cancer and HIV (Appleton, 
Gilman, Kubzansky, Buka, & Loucks, 2013; Danesh, Gholamrezaei, Torkzadeh, 
Mirbagher, Soluki & Emami, 2015; Kiecolt-Glaser, McGuire & Robles, 2002), 
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elucidating the relationship between ER, chronic and perceived stress, and IBD remains 
an important area of study.   
The first aim of this study was to investigate whether objective ratings of stress 
would account for a unique amount of variance in the relationship between stress and 
IBD disease severity. Contrary to expectation, neither perceived nor objectively rated 
stress arose as significant predictors of disease severity within this sample. This finding 
adds to a mixed body of literature with respect to the relationship between stress and IBD 
severity. For instance, while it has been observed that perceived stress is significantly 
related to symptom expression in both UC and CD (Targownik et al., 2015), and relapse 
into active disease states (Bernstein et al., 2010; Bitton et al., 2003), others have observed 
no true association between the two constructs (Keefer, Keshavarzian & Mutlu, 2008; 
Wahed & Rampton, 2013). For example, Wahed and Rampton (2013) investigated the 
impact of stress on IBD disease course and discovered that while there were certainly 
many studies performed on the subject, there were “limited reliable data” on the impact 
of stress on IBD due to employed methodology concerns and an insufficient literature 
base on the topic. In a similar vein, Keefer and colleagues (2008) analyzed the literature 
base on methodology and conclusions of studies on IBD and stress relationships and 
posited that the way that stress has been historically measured and defined within this 
area of study makes it difficult to truly pin down the impact of stress on IBD. The current 
study, with results suggesting no association between perceived or objective stress and 
IBD disease severity, adds to the body of work that largely remains undecided regarding 
the impact of perceived stress upon disease severity. Future investigations may attend to 
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contemporary validated definitions and measures of perceived stress within the field in 
order to gain further clarity of insight into this relationship.   
 A related aim of this study was to investigate whether adaptive ER reduced the 
adverse effects of stress on disease severity, and whether maladaptive ER exacerbates 
such effects. A body of work suggests the utility of ER in attenuating the effects of stress 
(Bitton et al. 2008; Wang & Saudino, 2011). In fact, there is evidence indicating that an 
individual’s ER strategy use in response to stress is closely associated with incurred 
disease severity (Danese, Sans, & Fiocchi, 2004; Glaser & Kiecolt-Glaser, 2005; 
Scharloo et al, 1997).  Increased experience of stress has indeed evidenced association 
with “poorer coping to IBD”, thereby worsening IBD disease severity (Pellissier, 
Dantzer, Canini, Mathieu, & Bonaz, 2010; Sajadinejad, Asgari, Molavi, Kalantari & 
Abidi, 2012) and vice versa (Bernstein et al., 2010). Contrary to expectation, neither 
adaptive nor maladaptive ER repertoires moderated the effects of perceived and 
objectively rated stress within the current investigation. This observation may be due to 
the reality that there are many confounding variables that can contribute to observations 
of, or absence of, associations between perceived stress and employed coping strategies 
within this population. For example, Iglesias-Rey and colleagues (2013) determined that 
the significant association that they discovered between experienced stress and increased 
use of maladaptive ER strategies within their sample was at least partially due to a 
number of confounding factors (i.e. gender, education level, lower stress scores across the 
sample, clinical anxiety and depression levels). Future investigations on the relationship 
between stress experience, ER, and IBD disease severity may find it pertinent to 
acknowledge and control for these variables, as feasibly possible, in order to more 
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accurately explore the hypothesized relationship between stress and ER strategy 
utilization specifically. 
 While ER ultimately did not surface as a significant moderator of the relationship 
between stress and disease severity outcomes, both ER repertoires evidenced significant 
associations with IBD severity, whereby frequent use of adaptive responses was inversely 
linked to severity, while the use of maladaptive responses predicted worsened disease 
severity. These findings are in line with prior investigations on the effects of ER on IBD 
outcomes. Adaptive ER and maladaptive ER repertoires have indeed been shown to 
significantly lessen and worsen IBD disease severity respectively (Appleton, Gilman, 
Kubzansky, Buka, & Loucks, 2013; Goodhand & Rampton, 2008; Kuroki, Ohta & 
Sherriff-Tadano, 2010). For example, Appleton and colleagues (2013) studied the impact 
of coping strategies on inflammatory exacerbation in individuals with IBD and 
discovered that those who utilized more adaptive ER strategies experienced lessened 
disease severity, while those who utilized predominantly maladaptive ER strategies 
experienced worsened disease severity. Danesh et al. (2015) also observed notable 
associations between adaptive ER and maintained or decreased IBD disease severity. 
Indeed, Danesh and colleagues (2015) determined that increased use of maladaptive ER 
strategies was associated with increased disease severity, while use of adaptive ER 
strategies was associated with decreased symptom expression and increased quality of 
life for individuals with IBD. Results of the current study similarly suggest an association 
between adaptive ER strategy employment and altered IBD disease severity. ER, 
typically thought of as a “psychosocial mechanism” to deal with discomfort (Gross, 1998, 
2002; Kiecolt-Glaser, McGuire & Robles, 2002; Wang & Saudino, 2011), is shown here 
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as a factor with potential to directly impact IBD, an autoimmune and fluctuating disease, 
outcomes independent of stress experiences. 
6.1 Limitations 
 The results from this study should be interpreted with respect to several 
limitations. First, due to budgetary constraints, the study was able to recruit a relatively 
small sample of participants with IBD. This may have limited the statistical power of this 
study to detect effects of moderate or small magnitudes. It is feasible that a larger sample 
would have enabled this study to find the hypothesized relationships. Further, this sample 
was comprised of predominantly Caucasian identifying women in middle adulthood. 
Therefore, the findings of this study have limited generalizability as IBD affects men and 
women equally across ethnic and racial groups (Table I). Relatedly, IBD is most 
frequently diagnosed in individuals between ages 15 and 35, with a median age of 
approximately 31 years old (Crohn’s and Colitis Foundation of America, 2015; Sewitch, 
Abrahamowicz, Bitton, Daly, Wild, Cohen, Katz, Szego & Dobkin, 2001). The current 
investigation utilized an older sample with a mean age of 43, substantially different from 
the national average. As the current sample is older, it is possible that these individuals 
may have learned to more effectively deal with disease-related stressors over time 
(Crohn’s and Colitis Foundation of America, 2015). Another limitation of this study is 
the use of an objective measure of stress that relied on participants’ self-report rather than 
a biological index. Indeed, while the approach to objectively measure stress has been 
well-validated, its initial reliance on participants’ responses makes it susceptible to the 
same methodological challenges that plague self-report measures (e.g., limited self-
knowledge, poor recollection, and response bias). While more objective measures of 
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stress exist, such as cortisol assays, such methods are not without their own limitations. 
For example, cortisol levels are influenced by such factors as time of day, genetics, 
inflammation, sleep quality, internalizing conditions (i.e. depression), posture, waking 
cycles, and external environmental factors (Kiecolt-Glaser, McGuire & Robles, 2002; 
Hennig, Friebe, Ryl, Kramer, Bottcher & Netter, 2000; Stetler & Miller, 2005). For these 
reasons, it can be argued that use of an objective team rated measure of stress may not be 
any less valuable to this field of research. 
6.2 Strengths 
 While this study, as with other investigations, has its limitations, it also embodies 
notable strengths. Despite low sample size and diversity within this study, disease 
severity was “moderate” for 50% of participants, consistent with related investigation 
severity percentages (Sewitch, Abrahamowicz, Bitton, Daly, Wild, Cohen, Katz, Szego & 
Dobkin, 2001; Targownik, Sexton, Bernstein, Beatie, Sargent, Walker & Graff, 2015). A 
further strength of this study is that the sample was recruited nationally and was not 
regionally constrained through local hospital, clinic, and/or university recruitment as is 
typical for health-topic research. Another strength of this investigation was its 
methodological contribution to the study of stress within this field of research through 
use of a team-based measure of stress. Report bias is a concern largely attributed to the 
self-report measures of stress used frequently in this field of research, often leading to 
misleading or inconclusive results (Keefer, Keshavarzian & Mutlu, 2008; Wahed & 
Rampton, 2013); use of the UCLA Life Stress Interview (LSI) measure within the current 
investigation allowed for reduced likelihood of report biases given its team scoring 
approach.  
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6.3 Future Research and Implications 
While it is readily apparent that future replications of the current investigation 
could benefit from recruitment of both a larger and more representative sample, there are 
other modifications and/or additions to consider. First, future investigations into the 
relationship between stress, ER, and IBD disease severity may endeavor to collect 
participant cortisol levels and inflammatory biomarkers alongside use of the LSI. The 
incorporation of these methods may be indicated in order to 1. garner a more 
comprehensive picture of this model at the biological level and 2. gain further insight into 
the relationship between this interview measure and a biological measure of stress. As 
salivary cortisol levels appear to be greatly influenced by environmental and genetic 
factors, discussed prior, it would be important for researchers to focus attention to 
potential confounding variables (such as time of collection) (Stetler & Miller, 2005).  
Future investigations may also consider implementing research-informed 
interventions geared toward psychoeducation on ER and related disease consequences. 
Such interventions would allow individuals with IBD to learn, and potentially benefit 
from, adaptive ER strategies empirically tied to the improvement of individual life 
stressors and disease activity. Research on psychosocial mitigating factors, such as ER, 
for the harmful disease-related consequences of day-to-day life stressors can provide for 
accessible and inexpensive alternative treatment options to clients who are traditionally 
treated through expensive and invasive means. Currently recommended treatments for 
IBD-diagnosed individuals are largely pharmacological, with many associated side 
effects, and/or expensive, making these treatments harder to obtain for disadvantaged 
populations (Chron’s and Colitis Foundation of America, 2015; Gibson, Ng, 
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Ozminkowski, Wang, Buron, Goetzel & Maclean, 2008; Wolfe & Sirois, 2008). This 
investigation brings attention to the importance of ER as a disease-maintenance 
intervention for individuals with IBD with diverse ability and socioeconomic levels.  
Oftentimes, individuals with chronic diseases, including IBD, seek out care from 
a range of medical professionals, including gastroenterologists, psychologists, primary 
care providers, and nurse practitioners. As the field of health psychology is ever changing 
and evolving to embrace integrated primary care treatment models, the need to identify 
brief interventions geared toward patient education and disease self-management is quite 
salient. The incorporation of ER into healthcare provider offices as a modifiable strategy 
through which IBD can be contextualized and managed on an individual basis has the 
potential to not only empower chronically ill clients, but to change the very way IBD and 
other chronic diseases are treated.  
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Appendix A: Tables 
 
Table I.  Frequency and percentage values of sample characteristics (sex, race, and 
reported disease severity; N=30). 
Characteristics Frequency Percentage 
of Sample 
Sex   
 4 (Male) 13.3% 
 26 (Female) 86.7% 
Race   
 1 (A. American) 3.3% 
 29 (Caucasian) 96.7% 
Disease Severity   
 8 (Remission) 26.7% 
 4 (Mild) 13.3% 
 15 (Moderate) 50% 
 4 (Severe) 13.3% 
 
Note. Frequencies are to be considered out of total N=30 and percentages out of total=100%. 
 
 
Table II. Descriptive statistics and bivariate correlation of study variables 
(demographics, adaptive and maladaptive ER, perceived stress, and objectively rated 
measures of chronic stress; N=30). 
 
Variables M (SD) 1. 2. 3. 4. 5. 6. 7. 
1. Age 43 (13.14) --       
2. Sex -- --- --      
3. HBI 9.17 (4.86) -.10 .08 --     
4. PSS 29 (7.73) -.02 .07 .27 --    
5. LSI-CS 21.97(5.64) .16 .07 .07 .43* --   
6. MMR 37.67(8.46) -.26 .26 .43* .70*** .45* --  
7. AMR 54.47(8.25) .02 .10 -.52** .02 -.18 -.06 -- 
 
Note. Sex = 0 = male, 1 = female; HBI= Harvey Bradshaw Index (IBD Severity); PSS= Cohen’s Perceived 
Stress Scale; LSI-CS= UCLA Objective Chronic Stress; MMR= Maladaptive Emotion Regulation (FAM 
Scale); AMR= Adaptive Emotion Regulation (FAM Scale) ***p<.001, **p ≤ .01, *p ≤ .05 
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Table III. Analyses of PSS and LSI chronic stress unique contributions to disease 
severity. 
Predictor  Step 1   Step 2   Step 3  
 B SE b B SE b B SE b 
Age -.03 .07 -.08 -.03 .07 -.08 -.03 .07 -.07 
Sex .89 2.75 .06 -.57 2.85 -.04 -.60 2.91 -.04 
PSS    .20 .13 .31 .20 .14 .03 
LSI       -.01 .19 -.02 
R2  .01   .09   .09  
DR2  .01   .08   .00  
 
†p<.10 *p<.05 **p<.001 
 
 
Table IV. Moderation analyses of adaptive ER on disease severity in relation to self-
report perceived stress. 
  Step 1   Step 2   Step 3  
Predictor B SE b B SE b B SE b 
Age -.03 .07 -.08 -.03 .06 -.07 -.02 .07 -.04 
Sex .89 2.75 .06 .14 2.50 .01 .22 2.54 .02 
AMR    -.30 .10 -.50** -.29 .10 -.50** 
PSS    .19 .11 .30 .18 .12 .28 
PSSxAMR       -.01 .01 -.10 
R2  .01   .34   .34  
DR2  .01   .33*   .01  
 
†p<.10 *p<.05 **p<.001 
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Table V. Moderation analyses of maladaptive ER on disease severity in relation to self-
report perceived stress. 
  Step 1   Step 2   Step 3  
Predictor B SE b B SE b B SE b 
Age -.03 .07 -.08 .02 .07 .06 .02 .07 .05 
Sex .89 2.75 .06 -.84 2.70 -.06 -.50 2.75 -.03 
MMR    .31 .20 .52† .35 .16 .59* 
PSS    -.03 .17 -.05 -.08 .18 -.12 
PSSxMMR       .01 .02 .16 
R2  .01   .22   .24  
DR2  .01   .21*   .02  
 
†p<.10 *p<.05 **p<.001 
 
 
 
Table VI. Moderation analyses of adaptive ER on disease severity in relation to 
objectively rated chronic stress 
  Step 1   Step 2   Step 3  
Predictor B SE b B SE b B SE b 
Age -.03 .07 -.08 -.03 .07 -.08 -.03 .07 -.08 
Sex .89 2.75 .06 1.55 2.50 .11 1.54 2.55 .11 
AMR    -.30 .11 -.50* -.30 .11 -.50* 
LSI    .02 .16 .02 -.02 .17 -.02 
LSIxAMR       .001 .02 .01 
R2  .01   .26   .26  
DR2  .01   .25*   00  
 
†p<.10 *p<.05 **p<.001 
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Table VII. Moderation analyses of maladaptive ER on disease severity in relation to 
objectively rated chronic stress. 
  Step 1   Step 2   Step 3  
 B SE b B SE b B SE b 
Age -.03 .07 -.08 .04 .07 .10 .03 .08 .08 
Sex .89 2.75 .06 -1.13 2.62 -.08 -.10 2.70 -.07 
MMR    .34 .13 .58* .34 .13 .57* 
LSI    -.15 .18 -.17 -.13 .19 -.15 
LSIxMMR       -.01 .02 -.07 
R2  .01   .24   .24  
DR2  .01   .23*   .00  
 
*p<.05 **p<.001 
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Appendix B: Figures  
 
Figure 1. Conceptual moderation model of emotion regulation on stress and IBD disease 
severity. 
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Appendix C: IRB Approval Document 
Feb 10, 2017 
Dear Ilya Yaroslavsky,  
RE: IRB-FY2017-144 
        Emotion Regulation and Irritable Bowel Disease Study 
 
The IRB has reviewed and approved your application for the above named project, under 
the category noted below. Approval for use of human subjects in this research is for a 
one-year period as noted below. If your study extends beyond this approval period, you 
must contact this office to initiate an annual review of this research. 
 
Approval Category: Expedited, Category 7 
Approval Date:        Feb 10, 2017 
Expiration Date:      Feb 9, 2018  
 
By accepting this decision, you agree to notify the IRB of: (1) any additions to or changes 
in procedures for your study that modify the subjects’ risk in any way; and (2) any events 
that affect that safety or well-being of subjects. Notify the IRB of any revisions to the 
protocol, including the addition of researchers, prior to implementation.  
 
Thank you for your efforts to maintain compliance with the federal regulations for the 
protection of human subjects. Please let me know if you have any questions.  
 
Sincerely,  
 
Mary Jane Karpinski  
IRB Analyst  
Cleveland State University  
Sponsored Programs and Research Services  
(216) 687-3624  
m.karpinski2@csuohio.edu  
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Appendix D: Informed Consent Document 
Informed Consent                                                                                 
 
Project Title: Emotion Regulation and Inflammatory Bowel Disease 
You are being invited to participate in a research project conducted at Cleveland State 
University (CSU) by Psychology Department Graduate Student Sarah Ghose, and 
Psychology Department Undergraduate Student Katherine Petrochic, both of whom can 
be contacted by phone at 216-687-4576 or by email at csuibdcollab@gmail.com. 
The principal investigator of this study is CSU Psychology Department Faculty Dr. Ilya 
Yaroslavsky. He can be contacted with any questions or concerns at 216-687-9237 or by 
email at i.yaroslavsky@csuohio.edu. 
Purpose of the Study: 
We are interested in the role that emotion regulation plays in the relationship between 
emotions and Inflammatory Bowel Disease (IBD). It is our hope that findings from this 
project will be able to provide further insight into IBD and its treatment. 
Procedures: 
If you agree to participate in this study, you will be asked to: 
• Read and digitally sign this consent form. 
• Privately complete online surveys about your emotional states, stress, and IBD 
symptoms (45 minutes). 
• Participate in an interview with a researcher about your personal experience with 
stress and IBD over the phone (45 minutes). 
• Privately complete 3 minutes surveys on your cell phone 5 times a day over the 
next 7 days (about 15 minutes a day). This will involve you entering your 
telephone number and email address into the SurveySignal software in order to 
receive daily text messages that contain links to the online questionnaire (1 hour 
25 minutes). 
The study will require about 3 hours of your time, for which you will be paid up to $30.  
You will also have a chance to earn an additional $100 in a raffle at the end of the study. 
You will be compensated $15 for completing the online survey and the phone interview. 
You will further receive $5 for completing surveys on your phone, and an additional $10 
for completing at least 80%, or 31 out of 35, of those surveys.  You will receive 5 surveys 
a day for 7 days, or 35 surveys in total.  
To help you complete at least 80% of the surveys, we will: (1) send you text messages 
that contain a link to our survey only during times that you indicate that you are 
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available, (2) send you a reminder message if you have not completed the survey within 
15 minutes of receiving the survey link, and (3) send daily updates to your email about 
how many surveys you completed that day. 
For your safety, please refrain from attempting to answer the phone surveys while 
driving.  
Confidentiality (Privacy): 
All records of your participation in this study will be kept private. All digitally stored 
information will be kept on a secure drive at Cleveland State University. This means that 
access to your information will be limited to research personnel. Your information will be 
kept for at least three years. Your information will be erased through secure data disposal 
services. You can let us know at any time if you no longer wish to be contacted by us 
without penalty. In the event that you wish to no longer be contacted, please contact Dr. 
Yaroslavsky at the telephone number or email address provided in this document.  
There are a few limits to confidentiality, or privacy, in this study that you should be made 
aware of. Rarely we may need to let others know who you are in order to keep you or 
another person safe. This includes if you tell us that you plan to hurt or kill yourself or 
someone else. This also includes if you tell us that a child is being neglected or abused, 
and/or if an older person is being neglected or abused. 
Benefits/Risks: 
By completing this study, you will receive a payment of up to $30 for your time. You 
will also be entered into a raffle to win an additional $100 by completing at least 80% of 
surveys sent to your phone. Your chances for winning the $100 are 1 in 30 if everyone 
who participates completes 80% of the phone surveys. 
We will ask you questions about your emotions and IBD. Some questions may make you 
feel discomfort (e.g. “How often has the feeling of fatigue or being tired and worn out 
been a problem for you during the past 2 weeks”). To help you feel more comfortable, 
you can skip questions at any time that make you feel uncomfortable. You can also take 
breaks or stop participating in the study at any time. You may also speak with Dr. Ilya 
Yaroslavsky, who is a licensed Clinical Psychologist and CSU Psychology faculty 
member. You can seek additional aid through any online/in person support groups you 
may be a part of. You can also reach out to another mental health professional in your 
area. 
Voluntary Nature of the Study (Non-Participation Statement): 
Your participation in this study is completely voluntary. Your refusal or withdrawal from 
participation will be met with no penalty to your professional or personal life. You can 
refuse to answer any questions. Doing so will not jeopardize our use of your data or 
compensation for your time. 
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Participation Consent: 
☐By clicking the checkbox, you are stating that you understand the information in this 
form. You understand that you can contact a researcher with any questions you may have. 
You understand that you must be, and are, at least 18 years old with an IBD diagnosis. 
Further, you are stating that you understand the statement from the Institutional Review 
Board below. 
 
I understand that if I have any questions about my rights as a research subject I can 
contact the Institutional Review Board at (216) 687-3630. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
